Lumexa Imaging Holdings, Inc.

LMRI Healthcare Medical Devices

Lumexa Imaging Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.0 billion, up 7.82% from fiscal 2024. In the quarter to June 2026, revenue grew 7.82%, EPS grew 127.1% and free cash flow grew 257.5%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

10.64 0.14 −1.30%
Market cap
$1.0B
P/E
0.0×
Fwd P/E
14.2×
Dividend yield
—
F-score
n/a
Altman Z
0.96
Beneish M
−2.67
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Jun '25 Older periods
ROE
0.00% 0.00% — —

+3 more TTM periods

ROA
(5.51%) (3.51%) 0.00% —
ROIC
48.10% 48.32% 0.00% 0.00%
Return on Tangible Assets
(21.30%) (28.17%) 0.00% —
Average Days of Receivables
35.09 31.75 0.00 —
Free Cash Flow per Share
0.16 (0.24) (0.10) 0.14
Free Cash Flow
14.93 (22.88) (7.22) 10.04
Other line items

Show all line items

Columns are period end dates